381 related articles for article (PubMed ID: 34398260)
1. Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?
Aubry-Rozier B; Schwitzguebel A; Valerio F; Tanniger J; Paquier C; Berna C; Hügle T; Benaim C
Rheumatol Int; 2021 Oct; 41(10):1785-1794. PubMed ID: 34398260
[TBL] [Abstract][Full Text] [Related]
2. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.
Ritelli M; Chiarelli N; Cinquina V; Vezzoli M; Venturini M; Colombi M
Am J Med Genet A; 2024 Feb; 194(2):174-194. PubMed ID: 37774134
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey.
Teran-Wodzinski P; Kumar A
Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial of heavy shoulder strengthening exercise in patients with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome and long-lasting shoulder complaints: study protocol for the Shoulder-MOBILEX study.
Liaghat B; Skou ST; Søndergaard J; Boyle E; Søgaard K; Juul-Kristensen B
Trials; 2020 Dec; 21(1):992. PubMed ID: 33261635
[TBL] [Abstract][Full Text] [Related]
5. Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States.
Estrella E; Frazier PA
Disabil Rehabil; 2024 Feb; 46(4):731-740. PubMed ID: 36772820
[TBL] [Abstract][Full Text] [Related]
6. The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS).
Kucharik AH; Chang C
Clin Rev Allergy Immunol; 2020 Jun; 58(3):273-297. PubMed ID: 31267471
[TBL] [Abstract][Full Text] [Related]
7. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
Bennett SE; Walsh N; Moss T; Palmer S
Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520
[TBL] [Abstract][Full Text] [Related]
8. Does Muscle Strength Change Over Time in Patients With Hypermobile Ehlers-Danlos Syndrome/Hypermobility Spectrum Disorder? An Eight-Year Follow-Up Study.
Coussens M; Calders P; Lapauw B; Celie B; Banica T; De Wandele I; Pacey V; Malfait F; Rombaut L
Arthritis Care Res (Hoboken); 2021 Jul; 73(7):1041-1048. PubMed ID: 32293111
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular manifestations of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
Rashed ER; Ruiz Maya T; Black J; Fettig V; Kadian-Dodov D; Olin JW; Mehta L; Gelb BD; Kontorovich AR
Vasc Med; 2022 Jun; 27(3):283-289. PubMed ID: 35000503
[No Abstract] [Full Text] [Related]
10. Functional gastrointestinal disorders are increased in joint hypermobility-related disorders with concomitant postural orthostatic tachycardia syndrome.
Tai FWD; Palsson OS; Lam CY; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
Neurogastroenterol Motil; 2020 Dec; 32(12):e13975. PubMed ID: 32803794
[TBL] [Abstract][Full Text] [Related]
11. Functional neurological signs in hypermobile Ehlers-Danlos syndrome and hypermobile spectrum disorders with suspected neuropathic pain.
Fernandez A; Jaquet M; Aubry-Rozier B; Suter M; Aybek S; Berna C
Brain Behav; 2024 Feb; 14(2):e3441. PubMed ID: 38409931
[TBL] [Abstract][Full Text] [Related]
12. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.
Thwaites PA; Gibson PR; Burgell RE
J Gastroenterol Hepatol; 2022 Sep; 37(9):1693-1709. PubMed ID: 35750466
[TBL] [Abstract][Full Text] [Related]
13. Assessment of gastrointestinal function and its' effect on bone mineral density and body composition in hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome.
DiFrancisco-Donoghue J; Southard V; Margulies M; Jung MK; Allera A; Riley B
J Clin Densitom; 2022; 25(4):536-543. PubMed ID: 35945116
[TBL] [Abstract][Full Text] [Related]
14. Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders.
Menton SM; Fairweather D; Bruno KA; Thompson CC; Candelo E; Darakjian AA; Gehin JM; Jain A; Kotha A; Whelan ER; Li Z; Knight DRT; Rutt AL
Laryngoscope; 2024 Feb; 134(2):773-778. PubMed ID: 37597175
[TBL] [Abstract][Full Text] [Related]
15. Physical therapy interventions in generalized hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome: a scoping review.
Garreth Brittain M; Flanagan S; Foreman L; Teran-Wodzinski P
Disabil Rehabil; 2024 May; 46(10):1936-1953. PubMed ID: 37231592
[TBL] [Abstract][Full Text] [Related]
16. Clinical trajectory of hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders in older adults.
Anderson LK; Lane KR
J Am Assoc Nurse Pract; 2023 Oct; 35(10):605-612. PubMed ID: 37261967
[TBL] [Abstract][Full Text] [Related]
17. Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder.
Brock I; Prendergast W; Maitland A
Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):473-481. PubMed ID: 34747107
[TBL] [Abstract][Full Text] [Related]
18. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome.
Lam CY; Palsson OS; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):277-287.e3. PubMed ID: 32109633
[TBL] [Abstract][Full Text] [Related]
19. The association of pain with gait spatiotemporal parameters in children with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.
Jeong HJ; Engel JM; Muriello M; Basel D; Slavens BA
Gait Posture; 2024 Mar; 109():271-276. PubMed ID: 38368648
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
